Innovation

Innovation backed
by evidence.

Guidance^® — our flagship platform — provides more informed treatment decisions. Our patented pooled antibiotic susceptibility testing accounts for bacterial interactions that may impact antibiotic resistance.

More about P-AST™ Evidence

Our Approach

Instead of relying on resistance gene information alone, Guidance^® UTI leverages Pooled Antibiotic Susceptibility Testing (P-AST™) — a unique technology that accounts for bacterial interactions in polymicrobial infections that may alter antibiotic resistance.¹

Tests for mutualism. Faster turnaround. Personalized results.

Guidance^® UTI leverages unique technology to transform patient care and champion antibiotic stewardship by better addressing polymicrobial infections, where bacterial interactions can impact antibiotic resistance. Guidance UTI helps providers direct personalized treatment to resolve infections in complicated UTIs.

While culture can take 3–5 days, Guidance UTI provides personalized results, including antibiotic susceptibility, in less than one day from receipt at lab‡ — reducing the need for empiric therapy and supporting antibiotic stewardship initiatives.

More about P-AST™ → Evidence →

Data Repository & Biobanking

A robust research resource that facilitates the exploration of biological determinants of health and disease.

Our large data repository includes over 300,000 cases of suspected UTI data. We compare positive vs. negative cases, polymicrobial cases, antibiotic susceptibility, and regional, seasonal, and demographic differences.

Clinical studies

Interested in participating? Contact us →

Completed studies

Multiplex PCR-Based Urinary Tract Infection (UTI) Analysis Compared to Traditional Urine Culture in Identifying Significant Pathogens in Symptomatic Patients — Retrospective UTI Urology Study
Multisite Prospective Comparison of Multiplex Polymerase Chain Reaction Testing with Urine Culture for Diagnosis of Urinary Tract Infections in Symptomatic Patients — Prospective UTI Urology Study
Utilization of M-PCR and P-AST for Diagnosis and Management of Urinary Tract Infections in Home-Based Primary Care — Retrospective Home Care UTI Study
Comparison of Guidance^® UTI and standard urine culture for rates of sepsis, hospitalization and other adverse outcomes in complicated urinary tract infections — Medicare Database Analysis Study

Ongoing studies

Comparison of Guidance^® UTI to standard urine culture regarding patient outcomes and physician decisions in elderly population, including long-term care setting — At Risk Study
Comparison of Guidance^® UTI to standard urine culture in outpatient setting regarding patient outcomes and physician decisions with mixed age population (NCT 05091931) — Mixed Age Study
NCT 04815369 — Nursing Home Study
Assess Guidance^® UTI safety and efficacy in a pediatric population, as compared to standard urine culture — Pediatric UTI Study

Coming soon

Wound Study

Want to put this evidence to work in your practice?

Talk to a Pathnostics representative about Guidance^® UTI and the underlying science.

Talk to a Rep See the Evidence

Vollstedt A, Baunoch D, Wolfe A, Luke N, Wojno KJ, et al. (2020). Bacterial Interactions as Detected by Pooled Antibiotic Susceptibility Testing (P-AST) in Polymicrobial Urine Specimens. J Sur urology, JSU-101. DOI: 10.29011/JSU-101.100001

Guidance UTI
with P-AST.

All Tests

Innovation backed
by evidence.

Tests for mutualism. Faster turnaround. Personalized results.

Clinical studies

Completed studies

Ongoing studies

Coming soon

Want to put this evidence to work in your practice?

Innovation backed by evidence.

Tests for mutualism. Faster turnaround. Personalized results.

Clinical studies

Completed studies

Ongoing studies

Coming soon

Want to put this evidence to work in your practice?

Innovation backed
by evidence.